Literature DB >> 8623869

Colonization with group B streptococci in pregnancy and adverse outcome. VIP Study Group.

J A Regan1, M A Klebanoff, R P Nugent, D A Eschenbach, W C Blackwelder, Y Lou, R S Gibbs, P J Rettig, D H Martin, R Edelman.   

Abstract

OBJECTIVE: Our purpose was to study the association of cervicovaginal colonization with group B streptococci with pregnancy and neonatal outcome. STUDY
DESIGN: A prospective study was conducted at seven medical centers between 1984 and 1989. Genital tract cultures were obtained at 23 to 26 weeks' gestation and at delivery. Prematurity and neonatal sepsis rates were compared between group B streptococci positive and negative women.
RESULTS: Group B streptococci was recovered from 2877 (21%) of 13,646 women at enrollment. Heavy colonization was associated with a significant risk of delivering a preterm infant who had a low birth weight (odds ratio = 1.5, 95% confidence interval 1.1 to 1.9). Heavily colonized women given antibiotics effective against group B streptococci had little increased risk of a preterm, low-birth-weight birth. Women with light colonization were at the same risk of adverse outcome as the uncolonized women. Neonatal group B streptococci sepsis occurred in 2.6 of 1000 live births in women with and 1.6 of 1000 live births in women without group B streptococci at 23 to 26 weeks' gestation (p = 0.11). However, sepsis occurred in 16 of 1000 live births to women with and 0.4 of 1000 live births to women without group B streptococci at delivery (p < 0.001).
CONCLUSIONS: Heavy group B streptococci colonization of 23 to 26 weeks' gestation was associated with an increased risk of delivering a preterm, low-birth-weight infant. Cervicovaginal colonization with group B streptococci at 23 to 26 weeks' gestation was not a reliable predictor of neonatal group B streptococci sepsis. Colonization at delivery was associated with sepsis.

Entities:  

Mesh:

Year:  1996        PMID: 8623869     DOI: 10.1016/s0002-9378(96)70684-1

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  52 in total

1.  Prevention of group B streptococcal infection in newborns: recommendation statement from the Canadian Task Force on Preventive Health Care.

Authors: 
Journal:  CMAJ       Date:  2002-04-02       Impact factor: 8.262

2.  Genetic features of Streptococcus agalactiae strains causing severe neonatal infections, as revealed by pulsed-field gel electrophoresis and hylB gene analysis.

Authors:  K Rolland; C Marois; V Siquier; B Cattier; R Quentin
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

3.  Infections in international pregnancy study: performance of the optical immunoassay test for detection of group B streptococcus.

Authors:  Jadsada Thinkhamrop; Sompop Limpongsanurak; Mario R Festin; Sean Daly; Anne Schuchat; Pisake Lumbiganon; Elizabeth Zell; Tsungai Chipato; Aye Aye Win; Mindy J Perilla; Jorge E Tolosa; Cynthia G Whitney
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

4.  Prevention of group B streptococcal infection in newborns. Recommendation statement from the Canadian Task Force on Preventive Health Care.

Authors: 
Journal:  Can Fam Physician       Date:  2002-05       Impact factor: 3.275

5.  ISSa4-based differentiation of Streptococcus agalactiae strains and identification of multiple target sites for ISSa4 insertions.

Authors:  Alexander Dmitriev; Adong Shen; Xuzhuang Shen; Yonghong Yang
Journal:  J Bacteriol       Date:  2004-02       Impact factor: 3.490

6.  Characterization of a novel leucine-rich repeat protein antigen from group B streptococci that elicits protective immunity.

Authors:  Ravin Seepersaud; Sean B Hanniffy; Peter Mayne; Phil Sizer; Richard Le Page; Jerry M Wells
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

7.  Activity of Genital Tract Secretions and Synthetic Antimicrobial Peptides against Group B Streptococcus.

Authors:  Nidhi Agarwal; Niall Buckley; Natasha Nakra; Philip Gialanella; Weirong Yuan; Jeny P Ghartey
Journal:  Am J Reprod Immunol       Date:  2015-09-23       Impact factor: 3.886

Review 8.  Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants.

Authors:  David Kaufman; Karen D Fairchild
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

Review 9.  Neonatal infectious diseases: evaluation of neonatal sepsis.

Authors:  Andres Camacho-Gonzalez; Paul W Spearman; Barbara J Stoll
Journal:  Pediatr Clin North Am       Date:  2013-01-17       Impact factor: 3.278

10.  Vaginal and oral microbes, host genotype and preterm birth.

Authors:  Usha Srinivasan; Dawn Misra; Mary L Marazita; Betsy Foxman
Journal:  Med Hypotheses       Date:  2009-12       Impact factor: 1.538

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.